PetMeds Q1 FY27 net loss narrows to $6.1 million; net sales fall 19.9% to $41 million

• PetMed Express posts Q1 net loss of USD 6.1 million, or USD 0.28 per share, narrowing from a year earlier.
• Net sales fall 19.9% year over year to USD 41 million on lower promotional usage and a decline in prescription medication sales.
• Adjusted EBITDA (non-GAAP) loss widens to USD 3.4 million from a year earlier.
• Technology transformation advances with an enterprise-wide rollout of a new SAP ERP system.
• Marketing efficiency improves, adding 70,000 new customers while cutting new-customer acquisition cost 15% year over year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PetMed Express Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608131605PRIMZONEFULLFEED9809753) on August 13, 2026, and is solely responsible for the information contained therein.